Byterna Therapeutics

Private

ShanghaiHealthcare & Life Scienceshttps://www.byterna.com/

Last Round

Angel

Dec 15, 2025

Total Funding Raised

$4.88M

Company Overview

Byterna Therapeutics is a biotechnology company that develops circular mRNA (cmRNA) therapeutics for cancer and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

circular mRNAcmRNAin vivo CAR-Tlipid nanoparticleLNPdrug discoveryAI drug designnext-gen mRNAbiotech R&Doncology therapeuticsautoimmune therapyRNA medicineprecision medicinecell therapysynthetic biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Byterna Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Byterna Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Byterna Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Angel	Dec 15, 2025
Angel	Oct 20, 2025
Grant	Nov 26, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Xian Zeng

Chief Executive Officer

Executive Team

Byterna Therapeutics Investors

Notable investors and investment history

Byterna Therapeutics investors
Investor	Rounds
Science and Technology Commission of Shanghai Municipality	Grant
Beijing Fangfu Venture Capital Management	Angel

View all Investors

Byterna Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Byterna Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Byterna Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Employee Range4

Year Founded2023

Last FundingDec 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.